Latest Cancer immunotherapy Stories
NEW YORK and ANN ARBOR, Mich., April 8, 2015 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company developing breakthrough
SAN DIEGO, April 6, 2015 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
New research report “Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons,
SEATTLE, March 30, 2015 /PRNewswire/ -- TapImmune Inc.
MARLBOROUGH, Mass., March 27, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license
SEATTLE, Mar. 25, 2015 /PRNewswire/ --TapImmune Inc.
BONN, Germany, March 24, 2015 /PRNewswire/ -- Brings Series A total to EUR14.25m to advance RNA-based immunotherapeutics for
NEW YORK and ANN ARBOR, Mich., March 19, 2015 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company developing breakthrough medicines
LOS ANGELES and MAASTRICHT, The Netherlands, March 19, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
SEATTLE, March 17, 2015 /PRNewswire/ -- Adaptive Biotechnologies Corporation, the pioneer in leveraging next generation sequencing to profile T-cell and B-cell receptors, today announced that members